Table 6 Subgroup analysis comparing 5-years, 3-years and 1-year mortality rates by cancer type in subjects with evidence of PC on cytology/imaging to subjects without evidence of PC
| Â | PC | No PC | P value |
|---|---|---|---|
5-Years | |||
 Breast | 16/31 (52%) | 4/10 (40%) | 0.63 |
 Gastric | 13/30 (43%) | 2/3 (67%) | 0.4 |
 Lung | 20/34 (59%) | 4/14 (29%) | 0.1 |
 Ovarian | 12/19 (63%) | 1/1 (100%) | 0.78 |
 Pancreatic | 19/28 (68%) | 4/12 (33%) | 0.04* |
 Renal | 7/20 (35%) | 2/6 (33%) | 0.12 |
 Colon | 16/28 (57%) | 2/5 (40%) | 0.44 |
3-Years | |||
 Breast | 15/31 (48%) | 3/10 (30%) | 0.43 |
 Gastric | 12/30 (40%) | 2/3 (67%) | 0.33 |
 Lung | 20/34 (59%) | 4/4 (100%) | 0.1 |
 Ovarian | 11/19 (58%) | 1/1 (100%) | 0.78 |
 Pancreatic | 17/28 (61%) | 4/4 (100%) | 0.08 |
 Renal | 11/20 (55%) | 1/6 (17%) | 0.09 |
 Colon | 16/28 (57%) | 2/5 (40%) | 0.44 |
1-Year | |||
 Breast | 6/31 (19%) | 3/10 (30%) | 0.56 |
 Gastric | 10/30 (33%) | 2/3 (67%) | 0.24 |
 Lung | 12/34 (35%) | 4/14 (29%) | 0.68 |
 Ovarian | 10/19 (53%) | 0/1 (0%) | 0.36 |
 Pancreatic | 16/28 (57%) | 2/12 (17%) | 0.02* |
 Renal | 8/20 (40%) | 0/6 (0%) | 0.08 |
 Colon | 10/28 (36%) | 1/5 (20%) | 0.47 |